If you liked this article you might like

Trader's Daily Notebook: Anemic Trading Would Be an Improvement

Will Illumina Maintain This Feverish Pace? Chart Shows What's Next

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers